Restricted accessReview articleFirst published online 2012-12
Reducing the Number of Laboratory Animals Used in Tissue Engineering Research by Restricting the Variety of Animal Models. Articular Cartilage Tissue Engineering as a Case Study
The use of laboratory animals in tissue engineering research is an important underexposed ethical issue. Several ethical questions may be raised about this use of animals. This article focuses on the possibilities of reducing the number of animals used. Given that there is considerable debate about the adequacy of the current animal models in tissue engineering research, we investigate whether it is possible to reduce the number of laboratory animals by selecting and using only those models that have greatest predictive value for future clinical application of the tissue engineered product. The field of articular cartilage tissue engineering is used as a case study. Based on a study of the scientific literature and interviews with leading experts in the field, an overview is provided of the animal models used and the advantages and disadvantages of each model, particularly in terms of extrapolation to the human situation. Starting from this overview, it is shown that, by skipping the small models and using only one large preclinical model, it is indeed possible to restrict the number of animal models, thereby reducing the number of laboratory animals used. Moreover, it is argued that the selection of animal models should become more evidence based and that researchers should seize more opportunities to choose or create characteristics in the animal models that increase their predictive value.
Get full access to this article
View all access options for this article.
References
1.
de VriesR.B.M., OerlemansA., TrommelmansL., DierickxK., GordijnB.Ethical Aspects of Tissue Engineering. A Review. Tissue Eng Part B, 14:367. 2008.
2.
TrommelmansL., SellingJ., DierickxK.Ethical reflections on clinical trials with human tissue engineered products. J Med Ethics, 34:e1. 2008.
3.
TrommelmansL., SellingJ., DierickxK.Informing participants in clinical trials with ex vivo human tissue-engineered products: what to tell and how to tell it?J Tissue Eng Regen Med, 2:236. 2008.
4.
TrommelmansL., SellingJ., DierickxK.The importance of the values attached to cells for a good informed consent procedure in cell donation for tissue engineering purposes. Cell Tissue Bank, 10:293. 2009.
5.
NordgrenA.Moral imagination in tissue engineering research on animal models. Biomaterials, 25:1723. 2004.
6.
RussellW.M.S., BurchR.L.The Principles of Humane Experimental Technique. London: Methuen, 1959.
7.
EderC., FalknerE., NehrerS., LosertU.M., SchöfflH.Introducing the concept of the 3Rs into tissue engineering research. ALTEX, 23:17. 2006.
8.
SteindlerD.A.Stem cells, regenerative medicine, and animal models of disease. ILAR J, 48:323. 2007.
9.
WakemanD.R., CrainA.M., SnyderE.Large animal models are critical for rationally advancing regenerative therapies. Reg Med, 1:405. 2006.
10.
BrittbergM.Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure. Am J Sports Med, 38:1259. 2010.
11.
BrittbergM.Autologous chondrocyte implantation—technique and long-term follow-up. Injury, 39,S1:S40. 2008.
12.
NakamuraN., MiyamaT., EngebretsenL., YoshikawaH., ShinoK.Cell-based therapy in articular cartilage lesions of the knee. Arthroscopy, 25:531. 2009.
13.
SafranM.R., SeiberK.The Evidence for Surgical Repair of Articular Cartilage in the Knee. J Am Acad Orthop Surg, 18:259. 2010.
14.
HarrisJ.D., SistonR.A., PanX., FlaniganD.C.Autologous chondrocyte implantation: a systematic review. J Bone Joint Surg Am, 92:2220. 2010.
15.
SarisD.B.F., BumaP., BulstraS.K.Guidance document Dutch Orthopaedic Association “Surgical treatment of cartilage defects in the knee” (in Dutch)2011. www.orthopeden.org/vereniging/pcrs. 2012 May 31.
16.
SarisD.B., VanlauweJ., VictorJ., HasplM., BohnsackM., FortemsY.et al.Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med, 36:235. 2008.
WiduchowskiW., WiduchowskiJ., TrzaskaT.Articular cartilage defects: study of 25,124 knee arthroscopies. Knee, 14:177. 2007.
19.
AhernB.J., ParvizJ., BostonR., SchaerT.P.Preclinical animal models in single site cartilage defect testing: a systematic review. Osteoarthr Cartilage, 17:705. 2009.
20.
AkensM.K., HurtigM.B.Influence of species and anatomical location on chondrocyte expansion. BMC Musculoskelet Disord, 6:23. 2005.
21.
BrittbergM., PetersonL., Sjogren-JanssonE., TallhedenT., LindahlA.Articular cartilage engineering with autologous chondrocyte transplantation. A review of recent developments. J Bone Joint Surg Am, 85-A,Suppl 3:109. 2003.
22.
ChiangH., JiangC.C.Repair of articular cartilage defects: review and perspectives. J Formos Med Assoc, 108:87. 2009.
23.
ChuC.R., SzczodryM., BrunoS.Animal models for cartilage regeneration and repair. Tissue Eng Part B, 16:105. 2010.
24.
FrisbieD.D., CrossM.W., McIlwraithC.W.A comparative study of articular cartilage thickness in the stifle of animal species used in human pre-clinical studies compared to articular cartilage thickness in the human knee. Vet Comp Orthop Traumatol, 3:142. 2006.
25.
Functional Tissue Engineering Conference Group. Evaluation criteria for musculoskeletal and craniofacial tissue engineering constructs: a conference report. Tissue Eng Part A, 14:2089. 2008.
GiannoniP., CrovaceA., MalpeliM., MaggiE., ArbicoR., CanceddaR.et al.Species variability in the differentiation potential of in vitro-expanded articular chondrocytes restricts predictive studies on cartilage repair using animal models. Tissue Eng, 11:237. 2005.
28.
GotterbarmT., BreuschS.J., SchneiderU., JungM.The minipig model for experimental chondral and osteochondral defect repair in tissue engineering: retrospective analysis of 180 defects. Lab Anim, 42:71. 2008.
29.
HabibovicP., WoodfieldT., de GrootK., van BlitterswijkC.Predictive value of in vitro and in vivo assays in bone and cartilage repair—what do they really tell us about the clinical performance?Adv Exp Med Biol, 585:327. 2006.
HunzikerE.B. Tissue engineering of bone and cartilage. From the preclinical model to the patient. Novartis Found Symp, 249:70. 2003.
32.
HunzikerE.B.Biologic repair of articular cartilage: defect models in experimental animals and matrix requirements. Clin Orthop Relat R, 367:S135. 1999.
33.
HunzikerE.B.Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthr Cartilage, 10:432. 2002.
34.
HunzikerE.B., SpectorM., LiberaJ., GertzmanA., WooS.L.Y., RatcliffeA.et al.Translation from Research to Applications. Tissue Eng, 12:3342. 2006.
35.
HurtigM.B., BuschmannM.D., FortierL.A., HoemannC.D., HunzikerE.B., JurvelinJ.S.et al.Preclinical studies for cartilage repair: recommendations from the international cartilage repair society. Cartilage, 2:137. 2011.
36.
KochT.G., BettsD.H.Stem cell therapy for joint problems using the horse as a clinically relevant animal model. Expert Opin Biol Ther, 7:1621. 2007.
37.
O'DriscollS.W.Preclinical cartilage repair: current status and future perspectives. Clin Orthop Relat Res391 Suppl:S397. 2001.
SarisD. B., DhertW. J., VerboutA. J.Joint homeostasis. The discrepancy between old and fresh defects in cartilage repair. J Bone Joint Surg Br, 85:1067. 2003.
40.
Schulze-TanzilG., MullerR.D., KohlB., SchneiderN., ErtelW., IpaktchiK.et al.Differing in vitro biology of equine, ovine, porcine and human articular chondrocytes derived from the knee joint: an immunomorphological study. Histochem Cell Biol, 131:219. 2009.
41.
SolchagaL.A., GoldbergV.M., CaplanA.I.Cartilage regeneration using principles of tissue engineering. Clin Orthop Relat Res391 Suppl:S161. 2001.
42.
AnY.H., FriedmanR.J.Animal models of articular cartilage defect. AnY.H., FriedmanR.J.Animal Models in Orthopaedic Research. Boca Raton: CRC Press, 1999; 309–325.
43.
ASTM. Standard F 2451-05: Standard Guide for in vivo Assessment of Implantable Devices Intended to Repair or Regenerate Articular Cartilage. 2005. www.astm.org/standards/F2451,htm. 2012 May 31.
JukesJ., MoroniL., van BlitterswijkC., de BoerJ.Critical Steps toward a Tissue-Engineered Cartilage Implant Using Embryonic Stem Cells. Tissue Eng Part A, 14:135. 2008.
47.
BumaP., PieperJ.S., van TienenT., van SusanteJ.L., van der KraanP.M., VeerkampJ.H.et al.Cross-linked type I and type II collagenous matrices for the repair of full-thickness articular cartilage defects—a study in rabbits. Biomaterials, 24:3255. 2003.
48.
RasanenT., MessnerK.Regional variations of indentation stiffness and thickness of normal rabbit knee articular cartilage. J Biomed Mater Res, 31:519. 1996.
49.
SimonW.H.Scale effects in animal joints. I. Articular cartilage thickness and compressive stress. Arthritis Rheum, 13:244. 1970.
50.
WarrenM.A.Moral Status. Obligations to Persons and Other Living Things. Oxford: Oxford University Press, 1997.
DeGraziaD.Taking Animals Seriously: Mental Life and Moral Status. Cambridge: Cambridge University Press, 1996.
53.
DeGraziaD.Human-animal chimeras: human dignity, moral status, and species prejudice. Metaphilosophy, 38:309. 2007.
54.
BekoffM., AllenC., BurghardtG.M.The Cognitive Animal. Empirical and Theoretical Perspectives on Animal Cognition. Cambridge, MA: MIT Press, 2002.
55.
HeegerR.Reasonable partiality to domestic animals. Ethical Theory Moral Pract, 8:123. 2005.
56.
Burgess-JacksonK.Doing right by our animal companions. J Ethics, 2:159. 1998.
57.
SarisD.B., VanlauweJ., VictorJ., AlmqvistK.F., VerdonkR., BellemansJ.et al.Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med, 37,Suppl 1:10S. 2009.
58.
VanlauweJ., SarisD.B., VictorJ., AlmqvistK.F., BellemansJ., LuytenF.P.Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters. Am J Sports Med, 39:2566. 2011.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
